Eric A. Vasiliauskas, MD

Associate Clinical Director, Inflammatory Bowel Disease Program

Inflammatory Bowel Disease Center
8730 Alden Drive
Suite 2E
Los Angeles, CA 90048





Eric A. Vasiliauskas, MD

Associate Clinical Director, Inflammatory Bowel Disease Program

  • IM/Gastroenterology
  • Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (IBD) - Pediatric

Nutrition Counseling

Eric A. Vasiliauskas, MD, is an internationally recognized expert in both adult and pediatric inflammatory bowel disease (IBD). As director of the Cedars-Sinai Nutrition and Integrative IBD Program, Dr. Vasiliauskas has been exploring and examining the influences and role of nutrition, diet manipulations and supplements—including herbal products and probiotics—on disease activity and specific symptoms in the management of Crohn’s disease, ulcerative colitis, microscopic colitis and IBD-associated small intestinal bacterial overgrowth. As a clinician and clinical researcher, he has focused and studied on how to optimize and fine-tune traditional anti-inflammatory, immunomodulatory and biologic therapies.

  • Medical School: University of Illinois College of Medicine, 1984
  • Internship: Children's Hospital Los Angeles, 1988
  • Residency: Children's Hospital Los Angeles, 1989
  • Fellowship: Children's Hospital Los Angeles, 1992
  • Fellowship: Cedars Sinai Medical Center, 1993

View CV as a PDF

  • Member, Cedars-Sinai Institutional Review Board
  • Member, Rapid Activation IRB
  • Vice-Chair, IRB-3
  • National Crohn’s & Colitis Foundation’s Professional Education Committee
  • National Crohn's & Colitis Foundation's Patient Education Committee
  • North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Committee
  • Best Doctors in Southern California, Recognized by Peers

Show moreShow less

Click here for a list of peer-reviewed publications.

  • North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, Oliva-Hemker M, Ziring D, Saeed S, Bousvaros A. Your Child with Inflammatory Bowel Disease: A Family Guide for Caregiving. 2017.
  • Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang HY, Targan SR. Marker antibody expression stratifies Crohn’s disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut. 2000;47(4):487-496.
  • Shih DQ, Nguyen M, Zheng L, Ibanez P, Mei L, Kwan LY, Bradford K, Ting C, Targan SR, Vasiliauskas EA. Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism. Aliment Pharmacol Ther. 2012;36(5):449-458.
  • Rutgeerts P, D'Haens G, Targan S, Vasiliauskas E, Hanauer SB, Present DH, Mayer L, van Hogezand RA, Braakman T, DeWoody KL, et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease. Gastroenterology. 1999;117(4):761-769.
  • Dubinsky MC, Yang HY, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology. 2002;122(4):904-915.
  • Mow WS, Lo SK, Targan SR, Dubinsky MC, Treyzon L, Abreu-Martin MT, Papadakis KA, Vasiliauskas EA. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2004;2(1):31-40.

Show moreShow less

English / Lithuanian / Spanish

Make an Appointment




Available 24 Hours A Day


Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Eric A. Vasiliauskas, MD